Literature DB >> 19900169

Chimpanzees in hepatitis C virus research: 1998-2007.

R H Bettauer1.   

Abstract

BACKGROUND: Chimpanzees have been widely used in hepatitis C virus (HCV) research, but their endangered status and high financial and ethical costs have prompted a closer review.
METHODS: One hundred and nine articles published in 1998-2007 were analyzed for the number of chimpanzees involved, experimental procedures, objectives and other relevant issues.
RESULTS: The articles described the use of 852 chimpanzees, but accounting for likely multiple uses, the number of individual chimpanzees involved here is estimated to be approximately 500. Most articles addressed immunology and inoculation studies. A significant portion of studies lasted for several months or years. Approximately one half of the individual chimpanzees were each used in 2-10 studies.
CONCLUSIONS: Significant financial and scientific resources have been expended in these chimpanzee HCV studies. Discussion addresses troublesome questions presented by some of the reviewed articles, including statistical validity, repeatability, and biological relevance of this model. These concerns merit attention as future approaches to HCV research and research priorities are considered.

Entities:  

Mesh:

Year:  2009        PMID: 19900169     DOI: 10.1111/j.1600-0684.2009.00390.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  12 in total

1.  Following Europe's lead, Congress moves to ban ape research.

Authors:  Stu Hutson
Journal:  Nat Med       Date:  2010-10       Impact factor: 53.440

2.  Animal rights: Chimpanzee research on trial.

Authors:  Meredith Wadman
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

3.  Colloquium paper: uniquely human evolution of sialic acid genetics and biology.

Authors:  Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

Review 4.  Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.

Authors:  Babs E Verstrepen; André Boonstra; Gerrit Koopman
Journal:  World J Hepatol       Date:  2015-01-27

5.  Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.

Authors:  Paula C Soto; Lance L Stein; Nancy Hurtado-Ziola; Stephen M Hedrick; Ajit Varki
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

6.  Limited MHC class II gene polymorphism in the West African chimpanzee is distributed maximally by haplotype diversity.

Authors:  Nel Otting; Natasja G de Groot; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2018-08-29       Impact factor: 2.846

7.  Human-specific evolution and adaptation led to major qualitative differences in the variable receptors of human and chimpanzee natural killer cells.

Authors:  Laurent Abi-Rached; Achim K Moesta; Raja Rajalingam; Lisbeth A Guethlein; Peter Parham
Journal:  PLoS Genet       Date:  2010-11-04       Impact factor: 5.917

8.  Chimpanzee susceptibility to hepatitis C virus infection correlates with presence of Pt-KIR3DS2 and Pt-KIR2DL9: paired activating and inhibitory natural killer cell receptors.

Authors:  Laurent Abi-Rached; Lisbeth A Guethlein; Paul J Norman; Peter Parham
Journal:  Immunogenetics       Date:  2015-08-12       Impact factor: 2.846

Review 9.  Vaccination for hepatitis C virus: closing in on an evasive target.

Authors:  John Halliday; Paul Klenerman; Eleanor Barnes
Journal:  Expert Rev Vaccines       Date:  2011-05       Impact factor: 5.217

Review 10.  Systematic reviews of animal models: methodology versus epistemology.

Authors:  Ray Greek; Andre Menache
Journal:  Int J Med Sci       Date:  2013-01-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.